These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20425631)

  • 41. Simultaneous biopsy and radiofrequency ablation of T1a renal cell carcinoma.
    Iguchi T; Hiraki T; Tomita K; Gobara H; Fujiwara H; Sakurai J; Matsui Y; Kanazawa S
    Diagn Interv Imaging; 2016 Nov; 97(11):1159-1164. PubMed ID: 27256108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imaging associated with percutaneous and intraoperative management of renal tumors.
    Anderson JK; Shingleton WB; Cadeddu JA
    Urol Clin North Am; 2006 Aug; 33(3):339-52. PubMed ID: 16829269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intermediate oncological outcomes of percutaneous radiofrequency ablation for small renal tumors: initial experience.
    Nitta Y; Tanaka T; Morimoto K; Makino T; Nishikawa N; Tashiro K; Naganuma T; Iguchi T; Matsuoka T; Nakatani T
    Anticancer Res; 2012 Feb; 32(2):615-8. PubMed ID: 22287753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laparoscopic radiofrequency ablation with intraoperative contrast-enhanced ultrasonography for T1bN0M0 renal tumors: initial functional and oncologic outcomes.
    Yang R; Lian H; Zhang G; Wang W; Gan W; Li X; Yan X; Zhang S; Zhao X; Guo H
    J Endourol; 2014 Jan; 28(1):4-9. PubMed ID: 23998802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
    Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
    World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors.
    Dai Y; Covarrubias D; Uppot R; Arellano RS
    J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ablative techniques: Radiofrequency and cryotherapy, which is the best?
    Lusch A; Graversen JA; Liss MA; Landman J
    Arch Esp Urol; 2013; 66(1):71-8. PubMed ID: 23406802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Percutaneous Renal Ablation.
    Gupta A; Musaddaq B; von Stempel C; Ilyas S
    Semin Ultrasound CT MR; 2020 Aug; 41(4):351-356. PubMed ID: 32620225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results.
    Su Li; Jarrett TW; Chan DY; Kavoussi LR; Solomon SB
    Urology; 2003 Apr; 61(4 Suppl 1):26-33. PubMed ID: 12657358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies.
    El Dib R; Touma NJ; Kapoor A
    BJU Int; 2012 Aug; 110(4):510-6. PubMed ID: 22304329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of renal tumors by percutaneous ultrasound-guided radiofrequency ablation using a multitined electrode: effectiveness and complications.
    del Cura JL; Zabala R; Iriarte JI; Unda M
    Eur Urol; 2010 Mar; 57(3):459-65. PubMed ID: 19926208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Percutaneous radiofrequency ablation of renal tumors: technique, limitations, and morbidity.
    Ogan K; Jacomides L; Dolmatch BL; Rivera FJ; Dellaria MF; Josephs SC; Cadeddu JA
    Urology; 2002 Dec; 60(6):954-8. PubMed ID: 12475648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CT and MR imaging after imaging-guided thermal ablation of renal neoplasms.
    Wile GE; Leyendecker JR; Krehbiel KA; Dyer RB; Zagoria RJ
    Radiographics; 2007; 27(2):325-39; discussion 339-40. PubMed ID: 17374856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Percutaneous radiofrequency ablation of the renal tumors. Initial clinical experience with minimally invasive therapy].
    Hoffmann P; Dvorák P; Morávek P; Safránek H
    Rozhl Chir; 2007 Sep; 86(9):494-9. PubMed ID: 17974143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Percutaneous radiofrequency ablation of small renal cell carcinoma: technique, complications, and outcomes.
    Popovic P; Lukic S; Mijailovic M; Salapura V; Garbajs M; Surlan Popovic K
    J BUON; 2012; 17(4):621-6. PubMed ID: 23335516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Solid renal masses: effectiveness and safety of image-guided percutaneous radiofrequency ablation.
    Iannuccilli JD; Dupuy DE; Mayo-Smith WW
    Abdom Imaging; 2012 Aug; 37(4):647-58. PubMed ID: 21968698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of imaging-guided percutaneous radiofrequency ablation for the treatment of biopsy-proven malignant cystic renal masses.
    Felker ER; Lee-Felker SA; Alpern L; Lu D; Raman SS
    AJR Am J Roentgenol; 2013 Nov; 201(5):1029-35. PubMed ID: 24147473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ablation of small renal masses: practice patterns at academic institutions in the United States.
    Patel SR; Abel EJ; Hedican SP; Nakada SY
    J Endourol; 2013 Feb; 27(2):158-61. PubMed ID: 22974005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictive factors for complete renal tumor ablation using RFA.
    Acosta Ruiz V; Lönnemark M; Brekkan E; Dahlman P; Wernroth L; Magnusson A
    Acta Radiol; 2016 Jul; 57(7):886-93. PubMed ID: 26452975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation.
    Hegarty NJ; Gill IS; Desai MM; Remer EM; O'Malley CM; Kaouk JH
    Urology; 2006 Jul; 68(1 Suppl):7-13. PubMed ID: 16857454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.